Professor Eneritus, Ohio State University
- Advisory Board: Arbor, Gowlings, Ironshore, Neuropharm, Novartis, Noven, Organon, Otsuka, Pfizer, Roche, Seaside Therapeutics, Sigma Tau, Shire, Tris Pharma, and Waypoint
- Research Support: Curemark, Forest, Lilly, Neuropharm, Novartis, Noven, Shire, Supernus, and YoungLiving, NIH and Autism Speaks
- Travel Support for participation in another meeting: Noven